The Role of Medical Structural Genomics in Discovering New Drugs for Infectious Diseases
Open Access
- 26 October 2009
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLoS Computational Biology
- Vol. 5 (10) , e1000530
- https://doi.org/10.1371/journal.pcbi.1000530
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment CrystallographyJournal of Medicinal Chemistry, 2009
- Image-based crystal detection: a machine-learning approachActa Crystallographica Section D-Biological Crystallography, 2008
- The plug-based nanovolume Microcapillary Protein Crystallization System (MPCS)Acta Crystallographica Section D-Biological Crystallography, 2008
- Shape Shifting Leads to Small-Molecule Allosteric Drug DiscoveryChemistry & Biology, 2008
- β-Hairpin Peptidomimetics: Design, Structures and Biological ActivitiesAccounts of Chemical Research, 2008
- Reaching for high-hanging fruit in drug discovery at protein–protein interfacesNature, 2007
- Antibacterial targets in fatty acid biosynthesisCurrent Opinion in Microbiology, 2007
- Heterocyclic α-helix mimetics for targeting protein–protein interactionsBioorganic & Medicinal Chemistry Letters, 2007
- The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB dataNucleic Acids Research, 2006
- Three-dimensional Structure of Influenza A N9 Neuraminidase and Its Complex with the Inhibitor 2-Deoxy 2,3-Dehydro-N-Acetyl Neuraminic AcidJournal of Molecular Biology, 1993